PD-L1-Positive High-Grade Triple-Negative Breast Cancer Patients Respond Better to Standard Neoadjuvant Treatment-A Retrospective Study of PD-L1 Expression in Relation to Different Clinicopathological Parameters.

J Clin Med · 2022 · PMC9573147 · PMID 36233396

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

They observed that positive PD-L1 expression by IC showed a trend for worse overall survival and distant metastasis-free survival in TNBC patients with neoadjuvant chemotherapy, which defines IC scoring system as the best prognostic marker [ 34 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.